Low dialysate sodium levels for chronic haemodialysis

钠 血液透析 医学 内科学 重症监护医学 材料科学 冶金
作者
Joanna Dunlop,Alain C. Vandal,Mark R. Marshall
出处
期刊:The Cochrane library [Wiley]
被引量:51
标识
DOI:10.1002/14651858.cd011204.pub2
摘要

Background Cardiovascular (CV) disease is the leading cause of death in dialysis patients, and strongly associated with fluid overload and hypertension. It is plausible that low dialysate [Na+] may decrease total body sodium content, thereby reducing fluid overload and hypertension, and ultimately reducing CV morbidity and mortality. Objectives This review evaluated harms and benefits of using a low (< 138 mM) dialysate [Na+] for maintenance haemodialysis (HD) patients. Search methods We searched the Cochrane Kidney and Transplant Register of Studies up to 7 August 2018 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. Selection criteria Randomised controlled trials (RCTs), both parallel and cross‐over, of low (< 138 mM) versus neutral (138 to 140 mM) or high (> 140 mM) dialysate [Na+] for maintenance HD patients were included. Data collection and analysis Two investigators independently screened studies for inclusion and extracted data. Statistical analyses were performed using random effects models, and results expressed as risk ratios (RR) for dichotomous outcomes, and mean differences (MD) or standardised MD (SMD) for continuous outcomes, with 95% confidence intervals (CI). Confidence in the evidence was assessed using GRADE. Main results We included 12 studies randomising 310 patients, with data available for 266 patients after dropout. All but one study evaluated a fixed concentration of low dialysate [Na+], and one profiled dialysate [Na+]. Three studies were parallel group, and the remaining nine cross‐over. Of the latter, only two used a washout between intervention and control periods. Most studies were short‐term with a median (interquartile range) follow‐up of 3 (3, 8.5) weeks. Two were of a single HD session, and two of a single week's HD. Half of the studies were conducted prior to 2000, and five reported use of obsolete HD practices. Risks of bias in the included studies were often high or unclear, lowering confidence in the results. Compared to neutral or high dialysate [Na+], low dialysate [Na+] had the following effects on "efficacy" endpoints: reduced interdialytic weight gain (10 studies: MD ‐0.35 kg, 95% CI ‐0.18 to ‐0.51; high certainty evidence); probably reduced predialysis mean arterial blood pressure (BP) (4 studies: MD ‐3.58 mmHg, 95% CI ‐5.46 to ‐1.69; moderate certainty evidence); probably reduced postdialysis mean arterial BP (MAP) (4 studies: MD ‐3.26 mmHg, 95% CI ‐1.70 to ‐4.82; moderate certainty evidence); probably reduced predialysis serum [Na+] (7 studies: MD ‐1.69 mM, 95% CI ‐2.36 to ‐1.02; moderate certainty evidence); may have reduced antihypertensive medication (2 studies: SMD ‐0.67 SD, 95% CI ‐1.07 to ‐0.28; low certainty evidence). Compared to neutral or high dialysate [Na+], low dialysate [Na+] had the following effects on "safety" endpoints: probably increased intradialytic hypotension events (9 studies: RR 1.56, 95% 1.17 to 2.07; moderate certainty evidence); probably increased intradialytic cramps (6 studies: RR 1.77, 95% 1.15 to 2.73; moderate certainty evidence). Compared to neutral or high dialysate [Na+], low dialysate [Na+] may make little or no difference to: intradialytic BP (2 studies: MD for systolic BP ‐3.99 mmHg, 95% CI ‐17.96 to 9.99; diastolic BP 1.33 mmHg, 95% CI ‐6.29 to 8.95; low certainty evidence); interdialytic BP (2 studies:, MD for systolic BP 0.17 mmHg, 95% CI ‐5.42 to 5.08; diastolic BP ‐2.00 mmHg, 95% CI ‐4.84 to 0.84; low certainty evidence); dietary salt intake (2 studies: MD ‐0.21g/d, 95% CI ‐0.48 to 0.06; low certainty evidence). Due to very low quality of evidence, it is uncertain whether low dialysate [Na+] changed extracellular fluid status, venous tone, arterial vascular resistance, left ventricular mass or volumes, thirst or fatigue. Studies did not examine cardiovascular or all‐cause mortality, cardiovascular events, or hospitalisation. Authors' conclusions It is likely that low dialysate [Na+] reduces intradialytic weight gain and BP, which are effects directionally associated with improved outcomes. However, the intervention probably also increases intradialytic hypotension and reduces serum [Na+], effects that are associated with increased mortality risk. The effect of the intervention on overall patient health and well‐being is unknown. Further evidence is needed in the form of longer‐term studies in contemporary settings, evaluating end‐organ effects in small‐scale mechanistic studies using optimal methods, and clinical outcomes in large‐scale multicentre RCTs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坚强孤容发布了新的文献求助10
刚刚
小易不易完成签到 ,获得积分10
刚刚
刚刚
qiu完成签到,获得积分10
刚刚
无花果的应助被bgxb采纳,获得10
1秒前
可爱的函函的应助被万里青山采纳,获得10
1秒前
Endless完成签到,获得积分10
1秒前
yao完成签到,获得积分10
1秒前
1秒前
糕糕完成签到 ,获得积分10
2秒前
科研小郭发布了新的文献求助30
2秒前
芒果完成签到,获得积分10
2秒前
科研通AI6.4的应助被LIUDAN采纳,获得10
2秒前
jinhongxuan发布了新的文献求助10
2秒前
3秒前
英姑的应助被Bieanle2022采纳,获得10
3秒前
Orange的应助被18387818005采纳,获得10
3秒前
3秒前
Anthea完成签到 ,获得积分10
4秒前
郑睿涛发布了新的文献求助10
4秒前
4秒前
samule3000发布了新的文献求助10
4秒前
4秒前
chi发布了新的文献求助10
5秒前
WuFen发布了新的文献求助20
5秒前
5秒前
谨慎枫叶完成签到,获得积分10
6秒前
科研通AI6.3的应助被芳非采纳,获得10
6秒前
6秒前
甜美坤完成签到 ,获得积分10
7秒前
华仔的应助被坚强孤容采纳,获得10
7秒前
杰里西发布了新的文献求助10
7秒前
7秒前
7秒前
小马甲的应助被温暖砖头采纳,获得10
8秒前
8秒前
Unless完成签到,获得积分10
9秒前
9秒前
xue发布了新的文献求助10
9秒前
贪玩的筝发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183091
求助须知:如何正确求助?哪些是违规求助? 9572406
关于积分的说明 21825003
捐赠科研通 7779812
什么是DOI,文献DOI怎么找? 3433837
关于科研通互助平台的介绍 2558045
邀请新用户注册赠送积分活动 2480046